They found that the SV2A immunoreactivity was decreased in all specimens from patients with confirmed hippocampal sclerosis, whereas the SV2A protein expression in the hippocampus of rats in the chronic epileptic phase was also reduced, but only in those animals with a progressive form of epilepsy [44]. The gene discussed is SV2A; the disease is epilepsy.